User: Guest  Login
Title:

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.

Document type:
Journal Article
Author(s):
Gaitzsch, Erik; Passerini, Verena; Khatamzas, Elham; Strobl, Carolin D; Muenchhoff, Maximilian; Scherer, Clemens; Osterman, Andreas; Heide, Michael; Reischer, Anna; Subklewe, Marion; Leutbecher, Alexandra; Tast, Benjamin; Ruhle, Adrian; Weiglein, Tobias; Stecher, Stephanie-Susanne; Stemmler, Hans J; Dreyling, Martin; Girl, Philipp; Georgi, Enrico; Wölfel, Roman; Mateyka, Laura; D'Ippolito, Elvira; Schober, Kilian; Busch, Dirk H; Kager, Juliane; Spinner, Christoph D; Treiber, Matthias; Rasch, Seb...     »
Abstract:
The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and...     »
Journal title abbreviation:
Hemasphere
Year:
2021
Journal volume:
5
Journal issue:
7
Fulltext / DOI:
doi:10.1097/HS9.0000000000000603
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/34235400
TUM Institution:
608; II. Medizinische Klinik und Poliklinik (Gastroenterologie); Institut für Klinische Chemie und Pathobiochemie; Institut für Medizinische Mikrobiologie, Immunologie und Hygiene; Institut für Virologie
 BibTeX